Click
?
Link to access lecture schedules
Do you have any questions? (088) 2080369 - 2345622 Pharmacy_QAAU@pharm.aun.edu.eg
تحت رعاية معالى السيد الأستاذ الدكتور / أحمد المنشاوى - رئيس الجامعة ، والسيد الأستاذ الدكتور / أحمد محمد عبدالمولى - نائب رئيس الجامعة لشئون التعليم والطلاب ، قامت السيدة الأستاذ الدكتور / جيهان نبيل فتيح - عميد الكلية ، يرافقها السيد الأستاذ الدكتور / حسن رفعت حسن -وكيل الكلية لشئون التعليم والطلاب ، والسيدة الأستاذ الدكتور/ دينا فتح الله محمد _ وكيل الكلية لشئون الدراسات العليا والبحوث، بعمل جولة تفقدية للمدرجات والمعامل بمختلف الأقسام حيث إطمئنت سيادتها على توفير كافة إحتياجات وإمكانيات العملية التعليمية وعناصر الجودة والإنتهاء من كافة أعمال الصيانة وإعلان الجداول لكل الفرق الدراسية قبل إنطلاق العام الجامعى الجديد 2025/2026 م بما يضمن حسن سير العملية التعليمية على الوجه الأكمل .
تم ذلك يوم السبت الموافق ٢٠٢٥/٩/٢٠


A series of novel 2-oxoindolin-3-ylidene thiazole derivatives were designed and synthesized, inspired by the pharmacophoric features of the VEGFR-2 inhibitor sunitinib. These compounds were evaluated for antiproliferative activity against a panel of sixty cancer cell lines at the US National Cancer Institute, identifying derivatives 4b, 4c, 4d, 4l, and 6c as the most potent, with mean growth inhibition percentages of 118.86%, 135.32%, 148.27%, 126.16%, and 78.46%, respectively. Further cytotoxicity assessments against the HepG2 cell line revealed IC50 values ranging from 3.13 to 30.54 μM. These compounds also demonstrated strong VEGFR-2 inhibition, with IC50 values of 0.113, 0.047, 1.549, 0.995, and 0.089 μM, respectively, compared to sunitinib's IC50 of 0.167 μM. Selectivity index analysis indicated high selectivity for HepG2 cells over THLE-2 normal cells (1.80–10.26), suggesting favourable safety profiles compared to sunitinib (1.15). Notably, compound 4c induced G0/G1 phase cell cycle arrest, promoted apoptosis, upregulated caspase-3 and -9 expression, and delayed wound closure by 60.74%. Molecular docking studies confirmed strong binding interactions within the VEGFR-2 active site, while in silico ADME and DFT analyses supported favourable pharmacokinetic properties and reactivity. These findings position compound 4c as a promising lead for the development of anticancer agents.
Click
?
below for the list of fourth-year students:
Click
?
Click
?
below for the list of students in Semester 7:
Click
?
below for the list of students in Semester 9:
The Faculty of Pharmacy – Assiut University announces the acceptance of all applicants for the Diploma and Doctor of Pharmacy degrees for the academic year 2025/2026.
All applicants for the PhD and Master’s degrees are requested to proceed to the Postgraduate Studies Administration at the Faculty to complete the required procedures.
With best wishes for continued success and excellence.
